Please wait while we load the requested 10-Q report or click the link below:
Q1 revenue of $2.82 billion, up 1% over $2.79 billion last year
Q1 diluted EPS of ($3.27), which include goodwill and other asset impairments of $4.43 per share
Q1 adjusted EPS of $2.37, which were negatively impacted by an estimated $0.55 per share from the COVID-19 pandemic
Q1 free cash flow of $97 million, up 36% over $72 million last year
LabCorp withdraws 2020 guidance and temporarily suspends its share repurchase program due to the unpredictability of the ongoing COVID-19 pandemic
LabCorp maintains a strong liquidity position and expects to deliver solid adjusted EPS and free cash flow in 2020
The following information was filed by Laboratory Corp Of America Holdings (LH) on Wednesday, April 29, 2020 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one quarter to another to evaluate Laboratory Corp Of America Holdings's financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were
removed , and by Laboratory Corp Of America Holdings.